NURECA
Back to All Ratios
|
NURECA Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | 1,494.46 | 103.88 | -112.51 | -1.79 | 559.74 |
What is the latest Core EBITDA Growth ratio of NURECA ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | 1,494.46 |
| Mar2024 | 103.88 |
| Mar2023 | -112.51 |
| Mar2022 | -1.79 |
| Mar2021 | 559.74 |
How is Core EBITDA Growth of NURECA Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | 1494.46 | 1,338.64 | |
| Mar2024 | 103.88 | Positive | |
| Mar2023 | -112.51 | Negative | |
| Mar2022 | -1.79 | Negative | |
| Mar2021 | 559.74 | - | |
Other Financial Ratios of NURECA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹318.4 Cr | 32.2% | 32.9% | 8.5% | Stock Analytics | |
| POLY MEDICURE | ₹19,472.2 Cr | 0.2% | -1.8% | -21% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | 32.2% |
32.9% |
8.5% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses